Approval · Notice of Compliance 7674 · 2006
VASOTEC: Notice of Compliance 7674
Issued January 6, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7674
- Date
- January 6, 2006
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Updating the indication for the treatment of essential or renovascular hypertension
- Therapeutic class
- Angiotensin converting enzyme inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VASOTEC | Not yet assigned | — |
Medicinal ingredients
- ENALAPRIL MALEATE 2.5 MG per TAB
- ENALAPRIL MALEATE 5 MG per TAB
- ENALAPRIL MALEATE 10 MG per TAB
- ENALAPRIL MALEATE 20 MG per TAB
- ENALAPRILAT 1.25 MG per ML